seminar stroke.4th rotation medicine

Upload: sofiyyah-zaihan

Post on 08-Apr-2018

223 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    1/68

    By

    Siti Nur Shafiqah Binti FazilMohammad Hazim Fikri Bin Adnan

    Mohd. Amirul Hafifi Bin KhairulzamanNor Akma Binti Sulaiman

    Norashikin Binti Naim

    Zafirah Hani Binti RamliAtika Azura Binti Abdul Rashed

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    2/68

    Public: weakness, usually permanent on oneside, often with loss of speech.

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    3/68

    Stroke is a clinical syndrome characterized by

    rapidly developing clinical symptoms and/or signs of

    focal, and at times global, loss of cerebral function,

    with symptoms lasting more than 24 hours or leading

    to death, with no apparent cause other than that of

    vascular origin.

    ~ Academy of Medicine, Malaysia

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    4/68

    Ischemic Hemorrhage

    - Sudden loss of fx dt loss of bloodsupply to an area that controls thatfx.

    - Usually caused bypartial/complete blockage of anartery that supplies the brain.

    - results from a weakenedvessel that ruptures andbleeds into the surroundingbrain.

    - blood accumulates andcompresses the surrounding

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    5/68

    HemorrhagicIschemic

    Corticol

    Lacunar

    Brainstem

    (85%) (15%)

    h ertension - Em olism- atheroma

    Large vessel

    - Throm osis- Em olism

    - Su arachnoidhemorrhage

    - Intracere ralhemorrhage

    - Mesothelioma

    Anteriorcirculation

    Posteriorcirculation

    Smallarteries

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    6/68

    NON-MODIFIABLE MODIFIABLE

    Age Hypertension (systolic and diastolic)

    Sex Cigarette smoking

    Ethnicity/race Diabetes Mellitus

    Family history of stroke Atrial fibrillation

    Coronary heart disease

    Hyperlipidemia

    Obesity and physical inactivity

    Raised homocysteine levelHigh dietary salt intake

    Heavy alcohol consumption

    Previous stroke

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    7/68

    Three main causes of ischaemic stroke are:

    1. Atherothromboembolism (50%)

    2. Intracranial small vessel disease (penetrating arterydisease) (25%)

    3. Cardiogenic embolism (20%)

    Other causes:

    Arterial dissection

    Trauma

    Vasculitis

    Metabolic disorder

    Congenital disorder

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    8/68

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    9/68

    Caused by :

    Extracranial embolism

    Intracranial thrombosis

    Decreased cerebral blood

    flow

    Necrosis of brain tissue

    Cerebral infarction

    Stroke

    Initiate ischaemic cascade

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    10/68

    1- Embolism

    May arise from the heart or extracranial arteries

    Sources of cardiogenic emboli : Valvular thrombi (MS, IE, prosthetic valve)

    Mural thrombi ( MI, AF)

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    11/68

    2- Thrombosis

    Large vessels (including carotid artery system) Small vessels (comprising intracerebral arteries,

    including the Circle of Willis & posterior circulation)

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    12/68

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    13/68

    3- Flow disturbances

    Inadequate cerebral blood flow due to :

    Decreased cerebral perfusion pressure

    Hematologic hyperviscosity ( sickle cell disease,multiple myeloma, polycythemia vera)

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    14/68

    Less common cause :

    polycythemia, sickle cell anemia, protein C deficiency,fibromuscular dysplasia of the cerebral arteries, andprolonged vasoconstriction from migraine headachedisorders.

    Any process that causes dissection of the cerebral arteries(trauma, thoracic aortic dissection, arteritis)

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    15/68

    Loss of perfusion to a portion of the brain

    unleashed the ischemic cascade

    On cellular level :

    Ischemic neurons become depolarized (ATP depleted)

    Membrane ion-transport systems fail

    Calcium influx release neurotransmitters (including

    glutamate)

    Activates N-methyl-D-Aspartate (NMDA) & otherexcitatory receptors on other neurons

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    16/68

    Neurons become depolarized

    Further calcium influx

    Further glutamate release

    Local amplification of initial ischemic insult

    + Massive calcium influx activates various degradative

    enzymes

    destruction of the cell membrane and otheressential neuronal structures

    + Free radicals, arachidonic acid, and nitric oxide aregenerated by this process further neuronal damage

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    17/68

    Intracerebral and subarachnoid hemorrhage

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    18/68

    Blood vessel ruptures

    Explosive entry of blood into the brain parenchyma.

    The extravasation forms a roughly circular or oval massthat disrupts the tissue and grows in volume as the

    bleeding continues.

    Swelling of brain tissue (cerebral edema)

    Adjacent brain tissue is distorted and compressed.

    Neurological deficit

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    19/68

    1- Intracranial hemorrhage

    Common : chronic high BP Weakens the arteries burst

    2- Subarachnoid hemorrhage

    Common : ruptured

    aneurysm

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    20/68

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    21/68

    Presentation of patient of stroke varies frommild confusion to altered level ofconsciousness, coma and death.

    The presentation are dependant on whatportion of the brain is damage.

    The areas of the brain affected by the strokedepend on the particular artery that is affected.

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    22/68

    Ischemic stroke

    Cortical

    Lacunar

    Brainstem

    Hemorrhagic stroke

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    23/68

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    24/68

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    25/68

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    26/68

    Anterior (carotid) artery circulation

    Middle cerebral arteryAphasia

    Hemiparesis / plegia

    Hemianopia

    Anterior cerebral artery

    personality changes

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    27/68

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    28/68

    Symptoms:

    Dizziness

    Diplopia

    Dysarthria

    Dysphagia

    Dystaxia

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    29/68

    Aphasia

    Agnosia

    Apraxia hemineglect

    Loss of consciousness

    Drowsy

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    30/68

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    31/68

    Definition:

    strokes caused by the occlusion of a small branch ofa larger blood vessel. Because of the way bloodvessels divide in the brain, lacunar strokes tend tooccur in areas located away from the surface of thebrain, where many of the smaller blood vesselbranches are located.

    Alert

    Normal cognitive function (absence of cortical signs)

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    32/68

    Pure motor stroke

    Pure Sensory

    Sensorimotor

    Ataxic Hemiparesis

    Dysarthria Clumsy-Hand Syndrome

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    33/68

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    34/68

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    35/68

    - dangerous: small portion but have many functions.

    : most patient die.

    Wallenberg's syndrome Horners syndrome Hemiparesis : corticospinal tract Diplopia: occulomotor Facial numbness and weakness: 5th and 7th cranial

    nerve Nystagmus and vertigo: vestibular Dysphagia and dysartria: 9th and 10th

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    36/68

    Dangerous within 24 hours.

    Clinical manifestation is almost the same, but usuallypatient with hemorrhagic stroke present with severe

    headache which sometimes preceed with vomitting.

    Differences between intracerebral and subarachnoidcan only be found radiologically. However, in severe

    hemorrhage, its difficult to distinguish between thetwo.

    Definite differences between hemorrhagic and

    infarction can only be seen radiologically.

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    37/68

    Metabolic/toxic encephalopathy Epileptic seizures ( Todds palsy) Hemiplegic migrain Structural intracranial lesion ( subdural

    hematoma, brain tumor, AVM) Encephalitis Head injury Relapsing multiple sclerosis

    Conversion disorder Hyperviscosity syndrome Peripheral nerves lesion ( guillaine barre

    syndrome)

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    38/68

    FBC, ESR, serumelectrolytes, serumcreatinine,liverfunctiontest, bloodglucose, lipidprofile,coagulationprofile, ABG

    - to detect common vascular risk factor and

    markers of rarer causes such as atherosclerosis,diabetis mellitus or blood clotting problem

    ECG, echocardiography, chest X-ray

    - should be considered if cardiac embolism is

    suspected Ctbrain

    -should be done as soon as possible in all patient

    to exclude or confirm hemorrhage

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    39/68

    MRI brainandMRA

    - should be considered if CT is negative (CT scan

    unable to differentiate ischemic andhemorrhagic stroke especially perfomed >10

    days after stroke)

    DopplerorDuplexultrasoundscan

    - this is used to find out whether there has beena narrowing of the blood vessels in the neck (the

    carotid arteries), which supply blood to the

    brain.

    Lumbarpuncture- should be done if subarachnoid hemorrhage is

    suspected and CT brain is negative

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    40/68

    Acute management

    Long-term management

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    41/68

    Airway check the patient can protect can protect his/her airway andswallow w/o evidence of aspiration

    Breathing check that the patient is breathing adequately; check O2

    saturation and give O2 if saturation < 95%Circulation check peripheral perfusion, pulse, and blood pressure

    adequate and treat w fluid replacement, anti-arrhythmics drugand inotropic drug as appropriate

    Hydration screen for sign of dehydration and give fluids parenterally orby nasogastric tube if necessary

    Nutrition assess nutritional status and provide nutritional supplementsif necessary; if dysphagia persist for a day or two, start feedingvia a nasogastric tube

    Medication if the patient is dysphagic, consider alternative routes foressential medications

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    42/68

    BP unless there is heart failure or renal failure, evidence ofhypertensive encephalopathy or aortic dissection, do not lowerthe blood pressure in the fist few week since the cerebrelperfusion may decrease. BP often returns towards the patientsnormal level within the first few days

    Bloodglucose

    check blood glucose and treat w insulin when levels are > 11.1mmol/L. monitor closely to avoid hypoglycemia

    Temperature check for pyrexia and investigate and treat underlying cause ;

    give antipyretics since raised brain temperature may increaseinfarct volume

    Pressuresarea

    check pressure areas and introduce measures to reduce the riskfor bedsores : treat infection, maintain nutrition, provide apressure-relieving mattress, turn immobile patient regularly

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    43/68

    Incontinence

    check for constipation and urinary retention and treatappropriately; avoid urinary catheterization unless the patient isin acute urinary retention or incontinence is threatening pressureareas

    Investigation

    CT/MRI, blood glucose, urea n electrolyte, FBC, INR, ESR, ECG

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    44/68

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    45/68

    Medical therapy Risk factor should be identified and addressed Risk factor are :

    HPT treat and monitor

    Smoking stop Lifestyle more active (exercise) Alcohol moderate intake/stop High cholesterol statins, diet Raised hematocrit reduce Atrial fibrillation anticoagulate

    Obesity weight reduction Diabetes good control Severe carotid stenosis - surgery Sleep apnoea - treat

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    46/68

    Antihypertensive therapy Recognition and good control of high BP is the major factor in both 1st and

    2nd stroke prevention. Transient HPT often seen following stroke usuallydoes not require treatment provided diastolic pressure does not rise > 100mmHg. Sustained severe HPT needs treatment. BP should be loweredslowly to avoid any sudden fall in perfusion.

    Antiplatelet therapy Long-term soluble aspirin(75 mg daily) reduces substantially the incidence

    of further infarction following thromboembolic TIA or stroke. Clopidogrel and dipyrimadole are also used Combined aspirin 75 mg daily and dipytidamole 200 mg twice daily

    possibly provide optimal prophylaxis against further thromboembolic

    stroke or TIA.

    Anticoagulants Heparin and warfarin shoud be given when there is atrial fibrillation

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    47/68

    Other measures Polycythaemia and any clotting abnormalities should be

    treated. Statin therapy should be given for all

    Surgical approaches Internal carotid endarterectomy

    Surgery is recommended in TIA or stroke patient with internalcarotid stenosis >70%.

    Successful surgery reduces the risk of further TIA/stroke byaround 75%.

    Endarterectomy has a mortality around 3% and a similar risk of

    stroke. Percutanous transluminal angioplasty (stenting) is an

    alternative. The value of surgery for asymtomatic carotid stenosis is

    debatable.

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    48/68

    Rehabilitation after stroke

    Optimal care is on a stroke rehabilitation unit that

    provides multidisciplinary services, coordinatesdisability-related medical care and trains caregivers.

    Physiotherapy*

    Speech therapy*

    Occupational therapy*

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    49/68

    Is particularly useful in the few weeks inreducing spasticity, relieving contractures andteaching patients to use walking aids.

    The benefits of physiotherapy for longer-termoutcome are still inadequately researched.

    Baclofen and/or botulinum toxin aresometimes helpful in the management ofsevere spasticity.

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    50/68

    Speech therapists have a vital understanding ofaphasic patients problem and frustration.

    Return of speech is hastened by conversation

    generally. If swallowing is unsafe because of the risk of

    aspiration, either nasogastric feeding orpercutanous gastrostomy will be needed.

    Video-fluoroscopy while attempting toswallow is helpful.

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    51/68

    Following recovery, the occupational therapistsplay a valuable role in assessing therequirement for and arranging the provision of

    various aids and modifications in the home,such as stair rails, hoists or wheelchairs.

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    52/68

    Anti-platelet- aspirin, clopidogrel, ticlopidine

    Anticoagulants-heparin, warfarin

    Thrombolytics-streptokinase, urokinase,t-PA

    Antihypertensiveagents

    ACE inhibitors

    Beta-blockers

    Hydralazine Lipidloweringdrugs

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    53/68

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    54/68

    ANTIPLATELETS

    Inhibition of prostaglandin mechanism

    Aspirin

    Inhibition of ADP-induced platelet aggregation Ticlodipine, clopidogrel

    Blockade of GP llb/llla receptors on platelets

    Abciximab, integrelin

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    55/68

    irreversibly inactivates platelet cyclooxygenase1 (through acetylation)and suppresses theproduction of thromboxane A2

    Interfere with platelet aggregation

    Anuclear platelet cannot synthesize newenzyme during its 10 day lifetime

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    56/68

    Irreversibly inhibit binding of ADP to itsreceptors on platelets

    Thus, inhibit activation of GP llb/IIIa receptors

    required for platelets to bind to fibrinogen andto each other

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    57/68

    ANTICOAGULANTS

    Heparin

    serve as a calatytic template to accelerate the

    antithrombin reaction antithrombin inhibits clotting factor proteases by

    forming stable complexes with them

    it interacts with activated factors (thrombin)IIa,

    IXa,Xa, providing anticoagulant effect withinminutes

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    58/68

    Warfarin

    Antagonist of vitamin K

    inhibit the synthesis of Vitamin K dependent clotting

    factors: factor II

    factor VII

    factor IX

    factor X

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    59/68

    THROMBOLYTICS

    Streptokinase

    Combines with ciculating plasminogen to form an

    activator complex: convert plasminogenplasmin t-PA (Alteplase, Reteplase)

    Preferentially activate plasminogen bound to fibrin confines fibrinolysis to the formed thrombus and

    avoids systemic activation

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    60/68

    ANTIHYPERTESIVE AGENTS

    IV betablockers

    hydralazine are recommended

    ACE inhibitors

    limited effect on cerebral circulation

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    61/68

    angiotensinogen

    Angiotensin 1

    Angiotensin 2

    Angiotensin 2 receptor

    vasoconstriction Aldosterone secretion

    Increase peripheral

    vascular resistanceIncreased sodium,

    Increase water retention

    Increased blood pressure

    ACE inhibitors

    Captopril, enapril, lisinopril, ramipril

    Inhibit peptidyl dipeptidase enzymeDecreased formation of angiotensin 2

    Decreased breakdown of bradykinin

    Angiotension

    receptor blocker

    Losartan, valsartan, irbesartan,candesarta

    Block angiotensin 2 receptorDo not have effect on bradykinin

    Similar benefits like ACE inhibitor

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    62/68

    Labetalol

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    63/68

    This drug causes direct vasodilation, actingprimarily on arteries and arterioles.

    This results in a decreased peripheral

    resistance, which in turn prompts a reflexelevation in heart rate and cardiac output.

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    64/68

    LIPID LOWERING DRUGS

    HMG CoA Reductase Inhibitor Bile acids binding resin

    Nicotinic acid

    Fibric acid derivatives

    Cholesterol absorption inhibitors

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    65/68

    HMG CoA reductase inhibitor

    Lovastatin, simvastatin, pravastatin, fluvastatin

    MOA: - analogs of 3-hydroxy-3-methylglutarate-competitive inhibitors of 3-H-3-M coenzyme A (HMG

    CoA reductase) which catalyze mevalonate biosynthesis

    HMG CoA mevalonate

    HMG CoA re uctase ihibitor

    Decreased de novo synthesis of cholesterol

    Increase LDL receptor number

    Increased LDL uptake by hepatocytes

    Decreased plasma LDL

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    66/68

    Bileacidbindingresin(cholestyramine,cholestipol,colesevelam)

    Nicotinic acid(niacin)

    Fibrates (clofibrate,benzafibrate,gemfibrozil)

    Cholesterolabsoprtioninhibitor(ezetimibe)

    MOA: binds to bileacid in the intestineand preventsreabsorbtion ;

    Enterohepaticcycling interuptedMore cholesterolneede to form bileacidOutcome:

    Increased de novesynthesis ofcholesterolIncreased LDL

    MOA: -decreasedintracellular lipaseactivityIncreased

    lipoprotein lipaseactivityDecrease catabolicrate of HDL

    MOA: - activateperoxixomeproliferator-activated receptor

    -Increasedexpression oflipoprotein lipase-Increasedcatabolism of VLDL

    MOA: inhibitintestinal absorptionof dietry and biliarycholesterol

    -reduce hepaticcholesterol stores-increase hepaticuptake of LDL fromplasma.

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    67/68

    Phychosocial Financial

    Sexual relationships changed.

    Most of the females lost interest intheir appearance, regardless of their

    age.

    felt unable to prevent outbursts andthis compounded their feelings ofguilt, low-esteem and despair.

    increase anger and feelings offrustration.

    Loss of self esteem makes depressioncommon

    Need to buy some equipment for thepatients for example, wheel chair, airbed, medication, pampers.

    The fees for physiotherapy andspeech therapist treatment.

    Many become unemployable, loseindependence and are financiallyembarrassed

  • 8/6/2019 Seminar Stroke.4th Rotation Medicine

    68/68

    Family members must be educated about howto take care of stroke patient

    Both the family and stroke patient must go for

    counseling in order to over come the problem Physiotherapy and speech therapy have an

    important psychological role, as it will increaseconfidence of stroke patients to live their life.